Effects of Daily or Cyclic Teriparatide on Bone Formation in the Iliac Crest in Women on No Prior Therapy and in Women on Alendronate

Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially

(2015) Tristan Whitmarsh et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate

(2015) Joy N. Tsai et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate

(2015) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

(2015) Benjamin Z Leder et al.   LANCET

Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density-The CONFORS Study

(2014) Christian Muschitz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study

(2014) Joy N Tsai et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

(2014) Benjamin Z. Leder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches

(2014) Felicia Cosman   Current Osteoporosis Reports

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

(2013) Joy N Tsai et al.   LANCET

Double and quadruple tetracycline labeling of bone: Impact of the label itself

(2012) Robert Lindsay et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density

(2012) Christian Muschitz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

(2012) David W Dempster et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene

(2012) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial

(2012) David W. Dempster et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Issues in modern bone histomorphometry

(2011) R.R. Recker et al.   BONE

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism

(2011) Mishaela R Rubin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

(2010) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

(2009) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

(2007) Steven Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM